Showing results (111-120 of 314) with videos related to
Sort By:
Pageof 32
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2014
Epithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progressionArun Satelli, Abhisek Mitra, Zachary Brownlee, et al.Neurosurgery|March 17, 2000
Pallidotomy microelectrode targeting: neurophysiology-based target refinementD L Kirschman, B Milligan, S Wilkinson, et al.Human Pathology|October 22, 2013
Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinomaMaryam Zenali, Michael J Overman, Asif Rashid, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2009
Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of VaterMichael J Overman, Gauri R Varadhachary, Scott Kopetz, et al.Cancer Treatment Reviews|July 1, 2025
Systematic literature review of intravenous versus subcutaneous administration of oncology therapies: A clinical, economic and patient perspectiveSaby George, Maria T Bourlon, Michael J Overman, et al.Cancer|September 2, 2008
Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinomaMichael J Overman, Scott Kopetz, Sijin Wen, et al.European Journal of Cancer (Oxford, England : 1990)|February 15, 2012
A multicenter, multinational analysis of mitomycin C in refractory metastatic colorectal cancerRenata Ferrarotto, Karime Machado, Milena P Mak, et al.Neurology|October 26, 1999
Bilateral thalamic stimulation for the treatment of essential tremorR Pahwa, K L Lyons, S B Wilkinson, et al.The Oncologist|June 1, 2019
Safety of Nivolumab plus Low-Dose Ipilimumab in Previously Treated Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal CancerMichael A Morse, Michael J Overman, Leighanne Hartman, et al.JAMA Oncology|August 16, 2019
Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018Jonathan M Loree, Seerat Anand, Arvind Dasari, et al.Pageof 32